0%
Vedacorp logo
Menu

India's Leading
Investment Bank

Providing strategic, financial, and tactical advice in connection with Capital Raising, M&A and Shareholder Engagements.

View Our Recent Advisory Transactions
200+

Transactions

$6Bn+

Transactions' Value

20+

Years' Track Record

Our Advisory Expertise

Capital Raise

Accelerate with the right capital

Financial & strategic advice in relation to capital raise from private equity, venture capital and other structured products.

Mergers & Acquisitions

Achieve synergies

M&A advisory in relation to sell-side advisory, buy-side advisory and joint
ventures.

Shareholder Engagement

Seasoned deal advisory partner

Cap-table restructuring, inter-se shareholder level advisory going beyond traditional
banking channels.

End-to-End Process Ownership

Homepage

Facilitate complex structuring

Liaising with external advisors on Tax efficiency, handling multiple entities across geographies & different holding structures.

Homepage

Control over timelines

Achieve optimal outcomes in the least possible timeframe without compromising on process.

Homepage

Managing objectives of all stakeholders

Company, operating promoters, incoming investors, exiting investors & non operating shareholders.

Creating High Impact Outcome
Over 20 Years

200+

Transactions

120+

PE/VC Deals

70+

M&A Deals &
Control PE Advisory

20+

PE Exits

10+

Structured Exits
Series A Growth | Series B/C Growth | Buyout/M&A | Late-Stage Growth | Structured Debt

Strong Track Record Across Sectors

Strong Track Record Across Sectors

35% |

Healthcare and Lifesciences

Homepage
Homepage
Homepage
Homepage
Homepage
Homepage

Our Recent Transactions

View all Transactions

July, 2024

Veda advises MG Cancer Hospital & Research Institute on its strategic divestment to HCG Healthcare & Life Sciences Veda advises MG Cancer Hospital & Research Institute on its strategic divestment to HCG
M&A Know MoreHomepage

June, 2024

Veda advises Omega Hospitals, India’s second largest oncology chain, in its Series A funding from Morgan Stanley Healthcare & Life Sciences Veda advises Omega Hospitals, India’s second largest oncology chain, in its Series A funding from Morgan Stanley
Private Equity Know MoreHomepage

June, 2024

Veda advises Indo-National on the sale of 51% stake in Kineco, a leading composites manufacturer Industrials Veda advises Indo-National on the sale of 51% stake in Kineco, a leading composites manufacturer
Private Equity Know MoreHomepage

May, 2024

Veda advised JJG Aero, a fast growing aerospace components manufacturer on its INR 1,000 Mn Series A fundraise from CX Partners Industrials Veda advised JJG Aero, a fast growing aerospace components manufacturer on its INR 1,000 Mn Series A fundraise from CX Partners
M&A Know MoreHomepage

May, 2024

VedaCorp advised Quintessence Business Solutions & Services on its acquisition by Firstsource Solutions Business Services VedaCorp advised Quintessence Business Solutions & Services on its acquisition by Firstsource Solutions
M&A Know MoreHomepage

March, 2024

VedaCorp advised Cureskin, an AI-driven dermatology platform on USD 20 Mn Series B fund raise from Healthquad and existing investors Retail and Consumer Internet VedaCorp advised Cureskin, an AI-driven dermatology platform on USD 20 Mn Series B fund raise from Healthquad and existing investors
Private Equity Know MoreHomepage

Delivered by a team with over
100 Years of Collective Experience

Meet the Team

Deep Network of Investors

Homepage

One of the only two Asian Investment Banks that are

Part of Infinita Alliance

Strong Relationships across Investor Types

PE Funds | VC Funds | Sector Focused Funds | DFIs and Impact Funds
Structured Finance funds | Pre-IPO Funds | Special Situations